288 related articles for article (PubMed ID: 32205992)
1. Role of spleen tyrosine kinase in liver diseases.
Kurniawan DW; Storm G; Prakash J; Bansal R
World J Gastroenterol; 2020 Mar; 26(10):1005-1019. PubMed ID: 32205992
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis.
Qu C; Zheng D; Li S; Liu Y; Lidofsky A; Holmes JA; Chen J; He L; Wei L; Liao Y; Yuan H; Jin Q; Lin Z; Hu Q; Jiang Y; Tu M; Chen X; Li W; Lin W; Fuchs BC; Chung RT; Hong J
Hepatology; 2018 Sep; 68(3):1125-1139. PubMed ID: 29537660
[TBL] [Abstract][Full Text] [Related]
3. The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases.
Zhao Y; Liu R; Li M; Liu P
Heliyon; 2022 Dec; 8(12):e12130. PubMed ID: 36568669
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitous role of spleen tyrosine kinase (Syk) in gut diseases: From mucosal immunity to targeted therapy.
Gong W; Liu P; Zheng T; Wu X; Zhao Y; Ren J
Int Rev Immunol; 2022; 41(5):552-563. PubMed ID: 34355656
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis.
Kurniawan DW; Jajoriya AK; Dhawan G; Mishra D; Argemi J; Bataller R; Storm G; Mishra DP; Prakash J; Bansal R
J Control Release; 2018 Oct; 288():227-238. PubMed ID: 30219279
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease.
Bukong TN; Iracheta-Vellve A; Saha B; Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Catalano D; Kodys K; Szabo G
Hepatology; 2016 Oct; 64(4):1057-71. PubMed ID: 27302565
[TBL] [Abstract][Full Text] [Related]
7. SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis.
Luci C; Vieira E; Bourinet M; Rousseau D; Bonnafous S; Patouraux S; Lefevre L; Larbret F; Prod'homme V; Iannelli A; Tran A; Anty R; Bailly-Maitre B; Deckert M; Gual P
Cell Mol Gastroenterol Hepatol; 2022; 13(1):173-191. PubMed ID: 34411785
[TBL] [Abstract][Full Text] [Related]
8. Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis.
Torres-Hernandez A; Wang W; Nikiforov Y; Tejada K; Torres L; Kalabin A; Wu Y; Haq MIU; Khan MY; Zhao Z; Su W; Camargo J; Hundeyin M; Diskin B; Adam S; Rossi JAK; Kurz E; Aykut B; Shadaloey SAA; Leinwand J; Miller G
Oncogene; 2019 Jun; 38(23):4512-4526. PubMed ID: 30742098
[TBL] [Abstract][Full Text] [Related]
9. Spleen Tyrosine Kinase as a Target Therapy for Pseudomonas aeruginosa Infection.
Alhazmi A
J Innate Immun; 2018; 10(4):255-263. PubMed ID: 29925062
[TBL] [Abstract][Full Text] [Related]
10. Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2-induced airway inflammation and remodeling.
Tabeling C; Herbert J; Hocke AC; Lamb DJ; Wollin SL; Erb KJ; Boiarina E; Movassagh H; Scheffel J; Doehn JM; Hippenstiel S; Maurer M; Gounni AS; Kuebler WM; Suttorp N; Witzenrath M
Allergy; 2017 Jul; 72(7):1061-1072. PubMed ID: 27906453
[TBL] [Abstract][Full Text] [Related]
11. Recent advance of spleen tyrosine kinase in diseases and drugs.
Shao Y; Zhang S; Zhang Y; Liu Z
Int Immunopharmacol; 2021 Jan; 90():107168. PubMed ID: 33264719
[TBL] [Abstract][Full Text] [Related]
12. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
13. Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells.
Aouar B; Kovarova D; Letard S; Font-Haro A; Florentin J; Weber J; Durantel D; Chaperot L; Plumas J; Trejbalova K; Hejnar J; Nunès JA; Olive D; Dubreuil P; Hirsch I; Stranska R
PLoS One; 2016; 11(6):e0156063. PubMed ID: 27258042
[TBL] [Abstract][Full Text] [Related]
14. Crystal Structures of Spleen Tyrosine Kinase in Complex with Two Novel 4-Aminopyrido[4,3-d] Pyrimidine Derivative Inhibitors.
Lee SJ; Choi JS; Bong SM; Hwang HJ; Lee J; Song HJ; Lee J; Kim JH; Koh JS; Lee BI
Mol Cells; 2018 Jun; 41(6):545-552. PubMed ID: 29890824
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases.
Zhou Y; Zhang Y; Yu W; Qin Y; He H; Dai F; Wang Y; Zhu F; Zhou G
Immun Inflamm Dis; 2023 Jul; 11(7):e934. PubMed ID: 37506139
[TBL] [Abstract][Full Text] [Related]
16. Spleen tyrosine kinase inhibition ameliorates airway inflammation through modulation of NLRP3 inflammosome and Th17/Treg axis.
Patel D; Gaikwad S; Challagundla N; Nivsarkar M; Agrawal-Rajput R
Int Immunopharmacol; 2018 Jan; 54():375-384. PubMed ID: 29202301
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosis.
Hu Q; Liu M; You Y; Zhou G; Chen Y; Yuan H; Xie L; Han S; Zhu K
Free Radic Biol Med; 2021 Nov; 175():193-205. PubMed ID: 34492311
[TBL] [Abstract][Full Text] [Related]
19. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
[TBL] [Abstract][Full Text] [Related]
20. Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK).
Wang Z; Qu S; Yuan J; Tian W; Xu J; Tao R; Sun S; Lu T; Tang W; Zhu Y
Bioorg Med Chem; 2023 Dec; 96():117514. PubMed ID: 37984216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
